Use of RZV in Immunocompromised Adults Aged > 19 Years Use of RZV in Immunocompromised Adults Aged > 19 Years

Recombinant zoster vaccine is the first herpes zoster vaccine approved for use in immunocompromised persons. Review its use in this population in this brief article.Morbidity & Mortality Weekly Report
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Public Health & Prevention Journal Article Source Type: news